Stuff’s headline ran “Vaccine hopes push sharemarket higher”.
An intriguing one, and sure enough Wall St had rallied on news the drug giant Johnson & Johnson had reported it expects to begin human clinical tests on a vaccine candidate for Covid-19 by September.
Point of Order went in search of other international developments being reported in the battle against the Covid-19 pandemic.
In the UK, the BBC reported a breathing aid that can help keep coronavirus patients out of intensive care has been created in under a week. University College London engineers worked with clinicians at UCLH and Mercedes Formula One to build the device, which delivers oxygen to the lungs without needing a ventilator.
Continuous Positive Airway Pressure (CPAP) devices are already used in hospitals but are in short supply. China and Italy used them to help Covid-19 patients.
The BBC said 40 of the new devices have been delivered to ULCH and to three other London hospitals. If trials go well, up to 1,000 of the CPAP machines can be produced per day by Mercedes-AMG-HPP, beginning in a week’.
The Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has already given its approval for their use. Continue reading “Here’s hoping Big Pharma come up quickly with something to beat Covid-19”